Clinical Trial Update: OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OKG-0301 in the treatment of adenoviral conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• OKG-0301

Snippet

Sponsor: Okogen | Conditions: Adenoviral Conjunctivitis | Phase 2 | Status: UNKNOWN